CERS vs REG · rev $201.3M vs P/E 34, $12.93B cap
Cerus Corporation (CERS) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
REG does not have a complete income-statement cache yet.
CERS currently screens at market cap $294.4M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the CERS and REG stock pages for the full models.
Not investment advice.